BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 38607056)

  • 21. MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model.
    Hsu FT; Wei ZH; Hsuan YC; Lin W; Su YC; Liao CH; Hsieh CL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S448-S459. PubMed ID: 30198338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution.
    Kim SM; Jeong CH; Woo JS; Ryu CH; Lee JH; Jeun SS
    Int J Nanomedicine; 2016; 11():13-23. PubMed ID: 26719691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
    Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
    Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration.
    Kwon S; Yoo KH; Sym SJ; Khang D
    Int J Nanomedicine; 2019; 14():5925-5942. PubMed ID: 31534331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
    Gomes ED; Vieira de Castro J; Costa BM; Salgado AJ
    Biochimie; 2018 Dec; 155():59-66. PubMed ID: 30031037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
    Kinoshita Y; Kamitani H; Mamun MH; Wasita B; Kazuki Y; Hiratsuka M; Oshimura M; Watanabe T
    Neurol Res; 2010 May; 32(4):429-37. PubMed ID: 19589205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
    Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
    Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival.
    Li Q; Wijesekera O; Salas SJ; Wang JY; Zhu M; Aprhys C; Chaichana KL; Chesler DA; Zhang H; Smith CL; Guerrero-Cazares H; Levchenko A; Quinones-Hinojosa A
    Clin Cancer Res; 2014 May; 20(9):2375-87. PubMed ID: 24789034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
    Lang FM; Hossain A; Gumin J; Momin EN; Shimizu Y; Ledbetter D; Shahar T; Yamashita S; Parker Kerrigan B; Fueyo J; Sawaya R; Lang FF
    Neuro Oncol; 2018 Feb; 20(3):380-390. PubMed ID: 29016843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
    Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
    Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal communication in glioma - a review.
    Xu H; Zhang K; Zong H; Shang M; Li K; He X
    J BUON; 2016; 21(6):1368-1373. PubMed ID: 28039693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
    Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
    J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model.
    Goodarzi A; Khanmohammadi M; Ai A; Khodayari H; Ai A; Farahani MS; Khodayari S; Ebrahimi-Barough S; Mohandesnezhad S; Ai J
    Mol Biol Rep; 2020 Oct; 47(10):7783-7795. PubMed ID: 32981013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.
    Balyasnikova IV; Prasol MS; Ferguson SD; Han Y; Ahmed AU; Gutova M; Tobias AL; Mustafi D; Rincón E; Zhang L; Aboody KS; Lesniak MS
    Mol Ther; 2014 Jan; 22(1):140-8. PubMed ID: 24002694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
    Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
    CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
    Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
    Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.